Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling

F. Sípos, O. Galamb, Barnabás Wichmann, T. Krenács, Kinga Tóth, Katalin Leiszter, G. Müzes, T. Zágoni, Z. Tulassay, B. Molnár

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A molecular diagnostic assay using easily accessible peripheral blood would greatly assist in the screening and diagnosis of ulcerative colitis (UC) and Crohn's disease (CD). Transcriptional profiles in blood/biopsy samples from 12 UC (6/12), 9 CD (5/9), 6 non-inflammatory bowel disease (non-IBD) colitis (6/0), and 11 healthy (11/11) patients were assessed by Affymetrix HGU133Plus2.0 microarrays. Prediction analysis of microarrays, discriminant and ROC analyses were performed, the results were validated by RT-PCR and immunohistochemistry using also an independent set of samples (15 blood samples, 45 biopsies). A set of 13 transcripts was differentially expressed in IBD, non-IBD controls and healthy blood samples (100% specificity and sensitivity). Validated difference was found in 16 transcripts between UC, non-IBD and normal blood, and 4 transcripts between CD, non-IBD and normal samples. UC and CD blood cases could be also distinguished by 5 genes with 100% specificity and sensitivity. Some disease associated alterations in blood transcripts were also detected in colonic tissue. IBD subtypes may be discriminated from non-IBD (diverticulitis, infective and ischemic colitis) in vitro from peripheral blood by screening for differential gene expression revealed in this study. Transcriptional profile alterations in peripheral blood can be located in diseased colon.

Original languageEnglish
Pages (from-to)1-17
Number of pages17
JournalDisease Markers
Volume30
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Gene Expression Profiling
Colitis
Ulcerative Colitis
Gene expression
Crohn Disease
Blood
Genes
Genome
Biopsy
Microarrays
Screening
Ischemic Colitis
Sensitivity and Specificity
Diverticulitis
Disease control
Molecular Pathology
Hematologic Diseases
Discriminant Analysis
Microarray Analysis
ROC Curve

Keywords

  • blood
  • gene expression profile
  • IBD
  • screening
  • tissue microarray

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry
  • Molecular Biology
  • Genetics

Cite this

@article{5f502a9cdd074e85821ce151336f411f,
title = "Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling",
abstract = "A molecular diagnostic assay using easily accessible peripheral blood would greatly assist in the screening and diagnosis of ulcerative colitis (UC) and Crohn's disease (CD). Transcriptional profiles in blood/biopsy samples from 12 UC (6/12), 9 CD (5/9), 6 non-inflammatory bowel disease (non-IBD) colitis (6/0), and 11 healthy (11/11) patients were assessed by Affymetrix HGU133Plus2.0 microarrays. Prediction analysis of microarrays, discriminant and ROC analyses were performed, the results were validated by RT-PCR and immunohistochemistry using also an independent set of samples (15 blood samples, 45 biopsies). A set of 13 transcripts was differentially expressed in IBD, non-IBD controls and healthy blood samples (100{\%} specificity and sensitivity). Validated difference was found in 16 transcripts between UC, non-IBD and normal blood, and 4 transcripts between CD, non-IBD and normal samples. UC and CD blood cases could be also distinguished by 5 genes with 100{\%} specificity and sensitivity. Some disease associated alterations in blood transcripts were also detected in colonic tissue. IBD subtypes may be discriminated from non-IBD (diverticulitis, infective and ischemic colitis) in vitro from peripheral blood by screening for differential gene expression revealed in this study. Transcriptional profile alterations in peripheral blood can be located in diseased colon.",
keywords = "blood, gene expression profile, IBD, screening, tissue microarray",
author = "F. S{\'i}pos and O. Galamb and Barnab{\'a}s Wichmann and T. Kren{\'a}cs and Kinga T{\'o}th and Katalin Leiszter and G. M{\"u}zes and T. Z{\'a}goni and Z. Tulassay and B. Moln{\'a}r",
year = "2011",
doi = "10.3233/DMA-2011-0758",
language = "English",
volume = "30",
pages = "1--17",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling

AU - Sípos, F.

AU - Galamb, O.

AU - Wichmann, Barnabás

AU - Krenács, T.

AU - Tóth, Kinga

AU - Leiszter, Katalin

AU - Müzes, G.

AU - Zágoni, T.

AU - Tulassay, Z.

AU - Molnár, B.

PY - 2011

Y1 - 2011

N2 - A molecular diagnostic assay using easily accessible peripheral blood would greatly assist in the screening and diagnosis of ulcerative colitis (UC) and Crohn's disease (CD). Transcriptional profiles in blood/biopsy samples from 12 UC (6/12), 9 CD (5/9), 6 non-inflammatory bowel disease (non-IBD) colitis (6/0), and 11 healthy (11/11) patients were assessed by Affymetrix HGU133Plus2.0 microarrays. Prediction analysis of microarrays, discriminant and ROC analyses were performed, the results were validated by RT-PCR and immunohistochemistry using also an independent set of samples (15 blood samples, 45 biopsies). A set of 13 transcripts was differentially expressed in IBD, non-IBD controls and healthy blood samples (100% specificity and sensitivity). Validated difference was found in 16 transcripts between UC, non-IBD and normal blood, and 4 transcripts between CD, non-IBD and normal samples. UC and CD blood cases could be also distinguished by 5 genes with 100% specificity and sensitivity. Some disease associated alterations in blood transcripts were also detected in colonic tissue. IBD subtypes may be discriminated from non-IBD (diverticulitis, infective and ischemic colitis) in vitro from peripheral blood by screening for differential gene expression revealed in this study. Transcriptional profile alterations in peripheral blood can be located in diseased colon.

AB - A molecular diagnostic assay using easily accessible peripheral blood would greatly assist in the screening and diagnosis of ulcerative colitis (UC) and Crohn's disease (CD). Transcriptional profiles in blood/biopsy samples from 12 UC (6/12), 9 CD (5/9), 6 non-inflammatory bowel disease (non-IBD) colitis (6/0), and 11 healthy (11/11) patients were assessed by Affymetrix HGU133Plus2.0 microarrays. Prediction analysis of microarrays, discriminant and ROC analyses were performed, the results were validated by RT-PCR and immunohistochemistry using also an independent set of samples (15 blood samples, 45 biopsies). A set of 13 transcripts was differentially expressed in IBD, non-IBD controls and healthy blood samples (100% specificity and sensitivity). Validated difference was found in 16 transcripts between UC, non-IBD and normal blood, and 4 transcripts between CD, non-IBD and normal samples. UC and CD blood cases could be also distinguished by 5 genes with 100% specificity and sensitivity. Some disease associated alterations in blood transcripts were also detected in colonic tissue. IBD subtypes may be discriminated from non-IBD (diverticulitis, infective and ischemic colitis) in vitro from peripheral blood by screening for differential gene expression revealed in this study. Transcriptional profile alterations in peripheral blood can be located in diseased colon.

KW - blood

KW - gene expression profile

KW - IBD

KW - screening

KW - tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=79955122823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955122823&partnerID=8YFLogxK

U2 - 10.3233/DMA-2011-0758

DO - 10.3233/DMA-2011-0758

M3 - Article

VL - 30

SP - 1

EP - 17

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

IS - 1

ER -